DiscGenics' Series B Round

DiscGenics raised a round of funding on September 26, 2017.

DiscGenics is a spinal therapeutics company using adult human disc-derived stem cells and tissue engineering techniques to treat patients debilitated by degenerative disc disease (DDD).…

Articles about DiscGenics' Series B Round: